ECS Botanics Holdings Limited (ASX: ECS) has been granted a Manufacture Licence by the Australian Federal Government’s Department of Health Office of Drug Control (ODC) for the operations of medical cannabis at its site in Tasmania.
- The licence allows the Company to undertake authorised activities for specified drugs upon development of its proposed medical cannabis facility at the site;
- The licence authorises ECS to undertake the manufacture of a drug in accordance with one or more manufacture permits;
- The licence was valid from 8 November 2019 till 8 November 2020.
At AEST 12:55PM, the stock was trading at $0.059 per share, up by 13.46% from its previous close.
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.